Request for Covid-19 Impact Assessment of this Report
The United States Testosterone Undecanoate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Testosterone Undecanoate market, reaching US$ million by the year 2028. As for the Europe Testosterone Undecanoate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Testosterone Undecanoate players cover Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, and Taro Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Undecanoate market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Testosterone Undecanoate Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Testosterone Undecanoate by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Testosterone Undecanoate by Country/Region, 2017, 2022 & 2028
2.2 Testosterone Undecanoate Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Testosterone Undecanoate Sales by Type
2.3.1 Global Testosterone Undecanoate Sales Market Share by Type (2017-2022)
2.3.2 Global Testosterone Undecanoate Revenue and Market Share by Type (2017-2022)
2.3.3 Global Testosterone Undecanoate Sale Price by Type (2017-2022)
2.4 Testosterone Undecanoate Segment by Application
2.4.1 Primary Hypogonadism
2.4.2 Hypogonadotropic Hypogonadism
2.4.3 Late-Onset Hypogonadism
2.5 Testosterone Undecanoate Sales by Application
2.5.1 Global Testosterone Undecanoate Sale Market Share by Application (2017-2022)
2.5.2 Global Testosterone Undecanoate Revenue and Market Share by Application (2017-2022)
2.5.3 Global Testosterone Undecanoate Sale Price by Application (2017-2022)
3 Global Testosterone Undecanoate by Company
3.1 Global Testosterone Undecanoate Breakdown Data by Company
3.1.1 Global Testosterone Undecanoate Annual Sales by Company (2020-2022)
3.1.2 Global Testosterone Undecanoate Sales Market Share by Company (2020-2022)
3.2 Global Testosterone Undecanoate Annual Revenue by Company (2020-2022)
3.2.1 Global Testosterone Undecanoate Revenue by Company (2020-2022)
3.2.2 Global Testosterone Undecanoate Revenue Market Share by Company (2020-2022)
3.3 Global Testosterone Undecanoate Sale Price by Company
3.4 Key Manufacturers Testosterone Undecanoate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Testosterone Undecanoate Product Location Distribution
3.4.2 Players Testosterone Undecanoate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Testosterone Undecanoate by Geographic Region
4.1 World Historic Testosterone Undecanoate Market Size by Geographic Region (2017-2022)
4.1.1 Global Testosterone Undecanoate Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Testosterone Undecanoate Annual Revenue by Geographic Region
4.2 World Historic Testosterone Undecanoate Market Size by Country/Region (2017-2022)
4.2.1 Global Testosterone Undecanoate Annual Sales by Country/Region (2017-2022)
4.2.2 Global Testosterone Undecanoate Annual Revenue by Country/Region
4.3 Americas Testosterone Undecanoate Sales Growth
4.4 APAC Testosterone Undecanoate Sales Growth
4.5 Europe Testosterone Undecanoate Sales Growth
4.6 Middle East & Africa Testosterone Undecanoate Sales Growth
5 Americas
5.1 Americas Testosterone Undecanoate Sales by Country
5.1.1 Americas Testosterone Undecanoate Sales by Country (2017-2022)
5.1.2 Americas Testosterone Undecanoate Revenue by Country (2017-2022)
5.2 Americas Testosterone Undecanoate Sales by Type
5.3 Americas Testosterone Undecanoate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Testosterone Undecanoate Sales by Region
6.1.1 APAC Testosterone Undecanoate Sales by Region (2017-2022)
6.1.2 APAC Testosterone Undecanoate Revenue by Region (2017-2022)
6.2 APAC Testosterone Undecanoate Sales by Type
6.3 APAC Testosterone Undecanoate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Testosterone Undecanoate by Country
7.1.1 Europe Testosterone Undecanoate Sales by Country (2017-2022)
7.1.2 Europe Testosterone Undecanoate Revenue by Country (2017-2022)
7.2 Europe Testosterone Undecanoate Sales by Type
7.3 Europe Testosterone Undecanoate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Testosterone Undecanoate by Country
8.1.1 Middle East & Africa Testosterone Undecanoate Sales by Country (2017-2022)
8.1.2 Middle East & Africa Testosterone Undecanoate Revenue by Country (2017-2022)
8.2 Middle East & Africa Testosterone Undecanoate Sales by Type
8.3 Middle East & Africa Testosterone Undecanoate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Undecanoate
10.3 Manufacturing Process Analysis of Testosterone Undecanoate
10.4 Industry Chain Structure of Testosterone Undecanoate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Testosterone Undecanoate Distributors
11.3 Testosterone Undecanoate Customer
12 World Forecast Review for Testosterone Undecanoate by Geographic Region
12.1 Global Testosterone Undecanoate Market Size Forecast by Region
12.1.1 Global Testosterone Undecanoate Forecast by Region (2023-2028)
12.1.2 Global Testosterone Undecanoate Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Testosterone Undecanoate Forecast by Type
12.7 Global Testosterone Undecanoate Forecast by Application
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Testosterone Undecanoate Product Offered
13.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Endo Pharmaceuticals
13.2.1 Endo Pharmaceuticals Company Information
13.2.2 Endo Pharmaceuticals Testosterone Undecanoate Product Offered
13.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Endo Pharmaceuticals Main Business Overview
13.2.5 Endo Pharmaceuticals Latest Developments
13.3 Merck Sharp & Dohme
13.3.1 Merck Sharp & Dohme Company Information
13.3.2 Merck Sharp & Dohme Testosterone Undecanoate Product Offered
13.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Sharp & Dohme Main Business Overview
13.3.5 Merck Sharp & Dohme Latest Developments
13.4 Taro Pharmaceutical
13.4.1 Taro Pharmaceutical Company Information
13.4.2 Taro Pharmaceutical Testosterone Undecanoate Product Offered
13.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Taro Pharmaceutical Main Business Overview
13.4.5 Taro Pharmaceutical Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Testosterone Undecanoate Product Offered
13.5.3 Cipla Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Zhejiang Xianju Pharmaceutical
13.6.1 Zhejiang Xianju Pharmaceutical Company Information
13.6.2 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Offered
13.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.6.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.7 Zhejiang Medicine Co.
13.7.1 Zhejiang Medicine Co. Company Information
13.7.2 Zhejiang Medicine Co. Testosterone Undecanoate Product Offered
13.7.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zhejiang Medicine Co. Main Business Overview
13.7.5 Zhejiang Medicine Co. Latest Developments
14 Research Findings and Conclusion
Table 1. Testosterone Undecanoate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Testosterone Undecanoate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)
Table 6. Global Testosterone Undecanoate Sales Market Share by Type (2017-2022)
Table 7. Global Testosterone Undecanoate Revenue by Type (2017-2022) & ($ million)
Table 8. Global Testosterone Undecanoate Revenue Market Share by Type (2017-2022)
Table 9. Global Testosterone Undecanoate Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)
Table 11. Global Testosterone Undecanoate Sales Market Share by Application (2017-2022)
Table 12. Global Testosterone Undecanoate Revenue by Application (2017-2022)
Table 13. Global Testosterone Undecanoate Revenue Market Share by Application (2017-2022)
Table 14. Global Testosterone Undecanoate Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Testosterone Undecanoate Sales by Company (2020-2022) & (K Units)
Table 16. Global Testosterone Undecanoate Sales Market Share by Company (2020-2022)
Table 17. Global Testosterone Undecanoate Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Testosterone Undecanoate Revenue Market Share by Company (2020-2022)
Table 19. Global Testosterone Undecanoate Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Testosterone Undecanoate Producing Area Distribution and Sales Area
Table 21. Players Testosterone Undecanoate Products Offered
Table 22. Testosterone Undecanoate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Testosterone Undecanoate Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Testosterone Undecanoate Sales Market Share Geographic Region (2017-2022)
Table 27. Global Testosterone Undecanoate Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Testosterone Undecanoate Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Testosterone Undecanoate Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Testosterone Undecanoate Sales Market Share by Country/Region (2017-2022)
Table 31. Global Testosterone Undecanoate Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Testosterone Undecanoate Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)
Table 34. Americas Testosterone Undecanoate Sales Market Share by Country (2017-2022)
Table 35. Americas Testosterone Undecanoate Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Testosterone Undecanoate Revenue Market Share by Country (2017-2022)
Table 37. Americas Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)
Table 38. Americas Testosterone Undecanoate Sales Market Share by Type (2017-2022)
Table 39. Americas Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)
Table 40. Americas Testosterone Undecanoate Sales Market Share by Application (2017-2022)
Table 41. APAC Testosterone Undecanoate Sales by Region (2017-2022) & (K Units)
Table 42. APAC Testosterone Undecanoate Sales Market Share by Region (2017-2022)
Table 43. APAC Testosterone Undecanoate Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Testosterone Undecanoate Revenue Market Share by Region (2017-2022)
Table 45. APAC Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)
Table 46. APAC Testosterone Undecanoate Sales Market Share by Type (2017-2022)
Table 47. APAC Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)
Table 48. APAC Testosterone Undecanoate Sales Market Share by Application (2017-2022)
Table 49. Europe Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)
Table 50. Europe Testosterone Undecanoate Sales Market Share by Country (2017-2022)
Table 51. Europe Testosterone Undecanoate Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Testosterone Undecanoate Revenue Market Share by Country (2017-2022)
Table 53. Europe Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)
Table 54. Europe Testosterone Undecanoate Sales Market Share by Type (2017-2022)
Table 55. Europe Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)
Table 56. Europe Testosterone Undecanoate Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Testosterone Undecanoate Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Testosterone Undecanoate Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Testosterone Undecanoate Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Testosterone Undecanoate Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Testosterone Undecanoate Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Testosterone Undecanoate
Table 66. Key Market Challenges & Risks of Testosterone Undecanoate
Table 67. Key Industry Trends of Testosterone Undecanoate
Table 68. Testosterone Undecanoate Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Testosterone Undecanoate Distributors List
Table 71. Testosterone Undecanoate Customer List
Table 72. Global Testosterone Undecanoate Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Testosterone Undecanoate Sales Market Forecast by Region
Table 74. Global Testosterone Undecanoate Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Testosterone Undecanoate Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Testosterone Undecanoate Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Testosterone Undecanoate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Testosterone Undecanoate Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Testosterone Undecanoate Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Testosterone Undecanoate Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Testosterone Undecanoate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Testosterone Undecanoate Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Testosterone Undecanoate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Testosterone Undecanoate Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Testosterone Undecanoate Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Testosterone Undecanoate Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Testosterone Undecanoate Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Testosterone Undecanoate Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Testosterone Undecanoate Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Testosterone Undecanoate Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Testosterone Undecanoate Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer AG Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer AG Testosterone Undecanoate Product Offered
Table 94. Bayer AG Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Bayer AG Main Business
Table 96. Bayer AG Latest Developments
Table 97. Endo Pharmaceuticals Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 98. Endo Pharmaceuticals Testosterone Undecanoate Product Offered
Table 99. Endo Pharmaceuticals Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Endo Pharmaceuticals Main Business
Table 101. Endo Pharmaceuticals Latest Developments
Table 102. Merck Sharp & Dohme Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Sharp & Dohme Testosterone Undecanoate Product Offered
Table 104. Merck Sharp & Dohme Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Merck Sharp & Dohme Main Business
Table 106. Merck Sharp & Dohme Latest Developments
Table 107. Taro Pharmaceutical Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 108. Taro Pharmaceutical Testosterone Undecanoate Product Offered
Table 109. Taro Pharmaceutical Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Taro Pharmaceutical Main Business
Table 111. Taro Pharmaceutical Latest Developments
Table 112. Cipla Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 113. Cipla Testosterone Undecanoate Product Offered
Table 114. Cipla Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Cipla Main Business
Table 116. Cipla Latest Developments
Table 117. Zhejiang Xianju Pharmaceutical Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Offered
Table 119. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Zhejiang Xianju Pharmaceutical Main Business
Table 121. Zhejiang Xianju Pharmaceutical Latest Developments
Table 122. Zhejiang Medicine Co. Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 123. Zhejiang Medicine Co. Testosterone Undecanoate Product Offered
Table 124. Zhejiang Medicine Co. Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Zhejiang Medicine Co. Main Business
Table 126. Zhejiang Medicine Co. Latest Developments
List of Figures
Figure 1. Picture of Testosterone Undecanoate
Figure 2. Testosterone Undecanoate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Testosterone Undecanoate Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Testosterone Undecanoate Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Testosterone Undecanoate Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Testosterone Undecanoate Sales Market Share by Type in 2021
Figure 12. Global Testosterone Undecanoate Revenue Market Share by Type (2017-2022)
Figure 13. Testosterone Undecanoate Consumed in Primary Hypogonadism
Figure 14. Global Testosterone Undecanoate Market: Primary Hypogonadism (2017-2022) & (K Units)
Figure 15. Testosterone Undecanoate Consumed in Hypogonadotropic Hypogonadism
Figure 16. Global Testosterone Undecanoate Market: Hypogonadotropic Hypogonadism (2017-2022) & (K Units)
Figure 17. Testosterone Undecanoate Consumed in Late-Onset Hypogonadism
Figure 18. Global Testosterone Undecanoate Market: Late-Onset Hypogonadism (2017-2022) & (K Units)
Figure 19. Global Testosterone Undecanoate Sales Market Share by Application (2017-2022)
Figure 20. Global Testosterone Undecanoate Revenue Market Share by Application in 2021
Figure 21. Testosterone Undecanoate Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Testosterone Undecanoate Revenue Market Share by Company in 2021
Figure 23. Global Testosterone Undecanoate Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Testosterone Undecanoate Revenue Market Share by Geographic Region in 2021
Figure 25. Global Testosterone Undecanoate Sales Market Share by Region (2017-2022)
Figure 26. Global Testosterone Undecanoate Revenue Market Share by Country/Region in 2021
Figure 27. Americas Testosterone Undecanoate Sales 2017-2022 (K Units)
Figure 28. Americas Testosterone Undecanoate Revenue 2017-2022 ($ Millions)
Figure 29. APAC Testosterone Undecanoate Sales 2017-2022 (K Units)
Figure 30. APAC Testosterone Undecanoate Revenue 2017-2022 ($ Millions)
Figure 31. Europe Testosterone Undecanoate Sales 2017-2022 (K Units)
Figure 32. Europe Testosterone Undecanoate Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Testosterone Undecanoate Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Testosterone Undecanoate Revenue 2017-2022 ($ Millions)
Figure 35. Americas Testosterone Undecanoate Sales Market Share by Country in 2021
Figure 36. Americas Testosterone Undecanoate Revenue Market Share by Country in 2021
Figure 37. United States Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Testosterone Undecanoate Sales Market Share by Region in 2021
Figure 42. APAC Testosterone Undecanoate Revenue Market Share by Regions in 2021
Figure 43. China Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Testosterone Undecanoate Sales Market Share by Country in 2021
Figure 50. Europe Testosterone Undecanoate Revenue Market Share by Country in 2021
Figure 51. Germany Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Testosterone Undecanoate Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Testosterone Undecanoate Revenue Market Share by Country in 2021
Figure 58. Egypt Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Testosterone Undecanoate Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Testosterone Undecanoate in 2021
Figure 64. Manufacturing Process Analysis of Testosterone Undecanoate
Figure 65. Industry Chain Structure of Testosterone Undecanoate
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...